Form D · Biotechnology

InvisiShield Technologies Ltd.

Emeryville, CA · CIK 0001913816

Offering snapshot reported Oct 3, 2022 · SEC filing

Reported sold
$2.5M
Offering amount: $2.5M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 26, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.25M$2.5MSep 30, 2022: $2,500,000.00Sep 30, 2022Oct 3, 2022: $2,500,000.00Oct 3, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 3, 2022Amendment$2,500,000$0vs Sep 30, 20224SEC filing
Sep 30, 2022Initial$2,500,000No comparison4SEC filing
Mar 15, 2022Initial$900,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-460400

Source: Form D, filed Oct 3, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cheng Liu Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5858 Horton Street, Suite 170
Emeryville, CA, 94608